Neoadjuvant chemoradiotherapy followed by esophagectomy versus definitive chemoradiotherapy in resectable stage II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-09

AUTHORS

Matsuo Nagata, Hiroshi Yamamoto, Nobuhiro Takiguchi, Osamu Kainuma, Akihiro Cho, Mikito Mori, Sohichi Narumoto, Takehide Asano, Kazuo Hatano

ABSTRACT

BackgroundThere are two intensive modalities for the treatment of resectable esophageal carcinoma: esophagectomy and definitive chemoradiotherapy (CRT). Esophagectomy with preoperative CRT was retrospectively compared with CRT alone in resectable stage II/III esophageal squamous cell carcinoma.MethodsSeventy-four patients with resectable stage II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma were treated with preoperative CRT by 5-fluorouracil (5-FU) 700 mg/m2 on days 1 to 5, nedaplatin 80 mg/m2 on day 1, and concurrent radiation for a total of 30 Gy in 3 weeks. If patients decided to undergo surgery, esophagectomy from the thoracoabdominal approach was carried out 6 weeks after the completion of CRT (CRT + Surg group, n = 51). If patients decided not to undergo surgery, they were treated with one more course of CRT (CRT-alone group, n = 23).ResultsThere was no significant difference in overall survival between the two groups (P = 0.1006), whereas the disease-free survival in the CRT + Surg group was improved compared with the CRT-alone group (P = 0.0186). In the patients with clinical stage III carcinoma or with regional lymph node metastasis, the overall survival rate was significantly improved in the CRT + Surg group compared with the CRT-alone group. The rate of local failures in the CRT + Surg group was significantly lower compared with the CRT-alone group (P = 0.0011).ConclusionsPreoperative CRT followed by esophagectomy provides better local control, but does not prolong overall survival, compared with definitive CRT. However, in clinical stage III or N1, esophagectomy with preoperative CRT could contribute to the improvement of survival in esophageal squamous cell carcinoma. More... »

PAGES

105-111

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10388-006-0081-9

DOI

http://dx.doi.org/10.1007/s10388-006-0081-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1012463847


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411321.4", 
          "name": [
            "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagata", 
        "givenName": "Matsuo", 
        "id": "sg:person.0750431225.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750431225.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411321.4", 
          "name": [
            "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamamoto", 
        "givenName": "Hiroshi", 
        "id": "sg:person.012252614265.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012252614265.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411321.4", 
          "name": [
            "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takiguchi", 
        "givenName": "Nobuhiro", 
        "id": "sg:person.0616257621.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616257621.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411321.4", 
          "name": [
            "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kainuma", 
        "givenName": "Osamu", 
        "id": "sg:person.0650435274.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650435274.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411321.4", 
          "name": [
            "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cho", 
        "givenName": "Akihiro", 
        "id": "sg:person.01043073521.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043073521.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411321.4", 
          "name": [
            "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mori", 
        "givenName": "Mikito", 
        "id": "sg:person.01133656514.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133656514.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411321.4", 
          "name": [
            "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Narumoto", 
        "givenName": "Sohichi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411321.4", 
          "name": [
            "Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Asano", 
        "givenName": "Takehide", 
        "id": "sg:person.01155213050.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155213050.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Radiation Therapy, Chiba Cancer Center Hospital, Chiba, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411321.4", 
          "name": [
            "Division of Radiation Therapy, Chiba Cancer Center Hospital, Chiba, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hatano", 
        "givenName": "Kazuo", 
        "id": "sg:person.0721671066.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721671066.13"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10147-003-0335-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035731497", 
          "https://doi.org/10.1007/s10147-003-0335-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/aso.2003.10.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051748188", 
          "https://doi.org/10.1245/aso.2003.10.014"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-09", 
    "datePublishedReg": "2006-09-01", 
    "description": "BackgroundThere are two intensive modalities for the treatment of resectable esophageal carcinoma: esophagectomy and definitive chemoradiotherapy (CRT). Esophagectomy with preoperative CRT was retrospectively compared with CRT alone in resectable stage II/III esophageal squamous cell carcinoma.MethodsSeventy-four patients with resectable stage II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma were treated with preoperative CRT by 5-fluorouracil (5-FU) 700\u2009mg/m2 on days 1 to 5, nedaplatin 80\u2009mg/m2 on day 1, and concurrent radiation for a total of 30\u2009Gy in 3 weeks. If patients decided to undergo surgery, esophagectomy from the thoracoabdominal approach was carried out 6 weeks after the completion of CRT (CRT + Surg group, n = 51). If patients decided not to undergo surgery, they were treated with one more course of CRT (CRT-alone group, n = 23).ResultsThere was no significant difference in overall survival between the two groups (P = 0.1006), whereas the disease-free survival in the CRT + Surg group was improved compared with the CRT-alone group (P = 0.0186). In the patients with clinical stage III carcinoma or with regional lymph node metastasis, the overall survival rate was significantly improved in the CRT + Surg group compared with the CRT-alone group. The rate of local failures in the CRT + Surg group was significantly lower compared with the CRT-alone group (P = 0.0011).ConclusionsPreoperative CRT followed by esophagectomy provides better local control, but does not prolong overall survival, compared with definitive CRT. However, in clinical stage III or N1, esophagectomy with preoperative CRT could contribute to the improvement of survival in esophageal squamous cell carcinoma.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10388-006-0081-9", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1033355", 
        "issn": [
          "1612-9059", 
          "1612-9067"
        ], 
        "name": "Esophagus", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "3"
      }
    ], 
    "keywords": [
      "stage II/III esophageal squamous cell carcinoma", 
      "esophageal squamous cell carcinoma", 
      "squamous cell carcinoma", 
      "SURG group", 
      "definitive chemoradiotherapy", 
      "cell carcinoma", 
      "preoperative chemoradiotherapy", 
      "overall survival", 
      "day 1", 
      "disease-free survival", 
      "regional lymph node metastasis", 
      "completion of chemoradiotherapy", 
      "resectable esophageal carcinoma", 
      "overall survival rate", 
      "good local control", 
      "clinical stage III", 
      "improvement of survival", 
      "lymph node metastasis", 
      "stage III carcinoma", 
      "neoadjuvant chemoradiotherapy", 
      "thoracoabdominal approach", 
      "concurrent radiation", 
      "node metastasis", 
      "esophageal carcinoma", 
      "chemoradiotherapy", 
      "intensive modalities", 
      "esophagectomy", 
      "stage III", 
      "local control", 
      "survival rate", 
      "carcinoma", 
      "patients", 
      "local failure", 
      "survival", 
      "more courses", 
      "significant differences", 
      "surgery", 
      "weeks", 
      "group", 
      "MethodsSeventy", 
      "ResultsThere", 
      "metastasis", 
      "BackgroundThere", 
      "modalities", 
      "treatment", 
      "total", 
      "m2", 
      "rate", 
      "failure", 
      "course", 
      "completion", 
      "differences", 
      "control", 
      "N1", 
      "improvement", 
      "radiation", 
      "approach", 
      "resectable stage II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma", 
      "II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma", 
      "III (T1-3N0, 1M0) esophageal squamous cell carcinoma", 
      "nedaplatin 80", 
      "CRT-alone group", 
      "clinical stage III carcinoma", 
      "III carcinoma", 
      "ConclusionsPreoperative CRT"
    ], 
    "name": "Neoadjuvant chemoradiotherapy followed by esophagectomy versus definitive chemoradiotherapy in resectable stage II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma", 
    "pagination": "105-111", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1012463847"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10388-006-0081-9"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10388-006-0081-9", 
      "https://app.dimensions.ai/details/publication/pub.1012463847"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:17", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_418.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10388-006-0081-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10388-006-0081-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10388-006-0081-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10388-006-0081-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10388-006-0081-9'


 

This table displays all metadata directly associated to this object as RDF triples.

188 TRIPLES      22 PREDICATES      93 URIs      83 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10388-006-0081-9 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N9c5ab8a8c2fc44898f7a13f5ab8dc889
4 schema:citation sg:pub.10.1007/s10147-003-0335-7
5 sg:pub.10.1245/aso.2003.10.014
6 schema:datePublished 2006-09
7 schema:datePublishedReg 2006-09-01
8 schema:description BackgroundThere are two intensive modalities for the treatment of resectable esophageal carcinoma: esophagectomy and definitive chemoradiotherapy (CRT). Esophagectomy with preoperative CRT was retrospectively compared with CRT alone in resectable stage II/III esophageal squamous cell carcinoma.MethodsSeventy-four patients with resectable stage II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma were treated with preoperative CRT by 5-fluorouracil (5-FU) 700 mg/m2 on days 1 to 5, nedaplatin 80 mg/m2 on day 1, and concurrent radiation for a total of 30 Gy in 3 weeks. If patients decided to undergo surgery, esophagectomy from the thoracoabdominal approach was carried out 6 weeks after the completion of CRT (CRT + Surg group, n = 51). If patients decided not to undergo surgery, they were treated with one more course of CRT (CRT-alone group, n = 23).ResultsThere was no significant difference in overall survival between the two groups (P = 0.1006), whereas the disease-free survival in the CRT + Surg group was improved compared with the CRT-alone group (P = 0.0186). In the patients with clinical stage III carcinoma or with regional lymph node metastasis, the overall survival rate was significantly improved in the CRT + Surg group compared with the CRT-alone group. The rate of local failures in the CRT + Surg group was significantly lower compared with the CRT-alone group (P = 0.0011).ConclusionsPreoperative CRT followed by esophagectomy provides better local control, but does not prolong overall survival, compared with definitive CRT. However, in clinical stage III or N1, esophagectomy with preoperative CRT could contribute to the improvement of survival in esophageal squamous cell carcinoma.
9 schema:genre article
10 schema:inLanguage en
11 schema:isAccessibleForFree false
12 schema:isPartOf N4d266b40651f4910b1933be84df92607
13 N59cab29043c94930852731cef026b30b
14 sg:journal.1033355
15 schema:keywords BackgroundThere
16 CRT-alone group
17 ConclusionsPreoperative CRT
18 II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma
19 III (T1-3N0, 1M0) esophageal squamous cell carcinoma
20 III carcinoma
21 MethodsSeventy
22 N1
23 ResultsThere
24 SURG group
25 approach
26 carcinoma
27 cell carcinoma
28 chemoradiotherapy
29 clinical stage III
30 clinical stage III carcinoma
31 completion
32 completion of chemoradiotherapy
33 concurrent radiation
34 control
35 course
36 day 1
37 definitive chemoradiotherapy
38 differences
39 disease-free survival
40 esophageal carcinoma
41 esophageal squamous cell carcinoma
42 esophagectomy
43 failure
44 good local control
45 group
46 improvement
47 improvement of survival
48 intensive modalities
49 local control
50 local failure
51 lymph node metastasis
52 m2
53 metastasis
54 modalities
55 more courses
56 nedaplatin 80
57 neoadjuvant chemoradiotherapy
58 node metastasis
59 overall survival
60 overall survival rate
61 patients
62 preoperative chemoradiotherapy
63 radiation
64 rate
65 regional lymph node metastasis
66 resectable esophageal carcinoma
67 resectable stage II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma
68 significant differences
69 squamous cell carcinoma
70 stage II/III esophageal squamous cell carcinoma
71 stage III
72 stage III carcinoma
73 surgery
74 survival
75 survival rate
76 thoracoabdominal approach
77 total
78 treatment
79 weeks
80 schema:name Neoadjuvant chemoradiotherapy followed by esophagectomy versus definitive chemoradiotherapy in resectable stage II/III (T1-3N0, 1M0) esophageal squamous cell carcinoma
81 schema:pagination 105-111
82 schema:productId N0509d1ff90ae42b9b7e81d6e67fc87fa
83 Nc3d1c60e5b5e43f485e21ff1791cd0a5
84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012463847
85 https://doi.org/10.1007/s10388-006-0081-9
86 schema:sdDatePublished 2021-12-01T19:17
87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
88 schema:sdPublisher N1547788133954999ba2d14494125806b
89 schema:url https://doi.org/10.1007/s10388-006-0081-9
90 sgo:license sg:explorer/license/
91 sgo:sdDataset articles
92 rdf:type schema:ScholarlyArticle
93 N0509d1ff90ae42b9b7e81d6e67fc87fa schema:name doi
94 schema:value 10.1007/s10388-006-0081-9
95 rdf:type schema:PropertyValue
96 N0f694ee6c5764695b3842add8d664845 rdf:first sg:person.01133656514.23
97 rdf:rest N7d7c80dcef4c436496956a49b70be6c0
98 N1547788133954999ba2d14494125806b schema:name Springer Nature - SN SciGraph project
99 rdf:type schema:Organization
100 N2079df93c96c4d3e93450ab2049becd2 rdf:first sg:person.012252614265.32
101 rdf:rest N5bc506f755b748a6a3af773b6102b530
102 N4d266b40651f4910b1933be84df92607 schema:issueNumber 3
103 rdf:type schema:PublicationIssue
104 N51cd567b48884c01996d66303381fb89 rdf:first sg:person.01155213050.85
105 rdf:rest Nc0ca631777674815b08bb5fee3e67641
106 N59cab29043c94930852731cef026b30b schema:volumeNumber 3
107 rdf:type schema:PublicationVolume
108 N5bc506f755b748a6a3af773b6102b530 rdf:first sg:person.0616257621.35
109 rdf:rest N923422754ee142b4be602e2b6565dd3f
110 N734fd9e0fe594524a6e42025912d099c rdf:first sg:person.01043073521.78
111 rdf:rest N0f694ee6c5764695b3842add8d664845
112 N7d7c80dcef4c436496956a49b70be6c0 rdf:first Nae7bb57f64bb41609197f40ed50502e3
113 rdf:rest N51cd567b48884c01996d66303381fb89
114 N923422754ee142b4be602e2b6565dd3f rdf:first sg:person.0650435274.38
115 rdf:rest N734fd9e0fe594524a6e42025912d099c
116 N9c5ab8a8c2fc44898f7a13f5ab8dc889 rdf:first sg:person.0750431225.05
117 rdf:rest N2079df93c96c4d3e93450ab2049becd2
118 Nae7bb57f64bb41609197f40ed50502e3 schema:affiliation grid-institutes:grid.411321.4
119 schema:familyName Narumoto
120 schema:givenName Sohichi
121 rdf:type schema:Person
122 Nc0ca631777674815b08bb5fee3e67641 rdf:first sg:person.0721671066.13
123 rdf:rest rdf:nil
124 Nc3d1c60e5b5e43f485e21ff1791cd0a5 schema:name dimensions_id
125 schema:value pub.1012463847
126 rdf:type schema:PropertyValue
127 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
128 schema:name Medical and Health Sciences
129 rdf:type schema:DefinedTerm
130 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
131 schema:name Oncology and Carcinogenesis
132 rdf:type schema:DefinedTerm
133 sg:journal.1033355 schema:issn 1612-9059
134 1612-9067
135 schema:name Esophagus
136 schema:publisher Springer Nature
137 rdf:type schema:Periodical
138 sg:person.01043073521.78 schema:affiliation grid-institutes:grid.411321.4
139 schema:familyName Cho
140 schema:givenName Akihiro
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043073521.78
142 rdf:type schema:Person
143 sg:person.01133656514.23 schema:affiliation grid-institutes:grid.411321.4
144 schema:familyName Mori
145 schema:givenName Mikito
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133656514.23
147 rdf:type schema:Person
148 sg:person.01155213050.85 schema:affiliation grid-institutes:grid.411321.4
149 schema:familyName Asano
150 schema:givenName Takehide
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155213050.85
152 rdf:type schema:Person
153 sg:person.012252614265.32 schema:affiliation grid-institutes:grid.411321.4
154 schema:familyName Yamamoto
155 schema:givenName Hiroshi
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012252614265.32
157 rdf:type schema:Person
158 sg:person.0616257621.35 schema:affiliation grid-institutes:grid.411321.4
159 schema:familyName Takiguchi
160 schema:givenName Nobuhiro
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616257621.35
162 rdf:type schema:Person
163 sg:person.0650435274.38 schema:affiliation grid-institutes:grid.411321.4
164 schema:familyName Kainuma
165 schema:givenName Osamu
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650435274.38
167 rdf:type schema:Person
168 sg:person.0721671066.13 schema:affiliation grid-institutes:grid.411321.4
169 schema:familyName Hatano
170 schema:givenName Kazuo
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721671066.13
172 rdf:type schema:Person
173 sg:person.0750431225.05 schema:affiliation grid-institutes:grid.411321.4
174 schema:familyName Nagata
175 schema:givenName Matsuo
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750431225.05
177 rdf:type schema:Person
178 sg:pub.10.1007/s10147-003-0335-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035731497
179 https://doi.org/10.1007/s10147-003-0335-7
180 rdf:type schema:CreativeWork
181 sg:pub.10.1245/aso.2003.10.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051748188
182 https://doi.org/10.1245/aso.2003.10.014
183 rdf:type schema:CreativeWork
184 grid-institutes:grid.411321.4 schema:alternateName Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan
185 Division of Radiation Therapy, Chiba Cancer Center Hospital, Chiba, Japan
186 schema:name Division of Gastroenterological Surgery, Chiba Cancer Center Hospital, 666-2 Nitona-cho, Chuo-ku, 260-8717, Chiba, Japan
187 Division of Radiation Therapy, Chiba Cancer Center Hospital, Chiba, Japan
188 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...